Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in<br /> high-grade myelodysplastic syndrome
Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in<br /> high-grade myelodysplastic syndrome
复制标题
作者：
刘立;史文慧;朱杨;赵佑山;顾树程;费成明;郭娟;吴东;周立宇;
